Pay in 4 interest-free payments of $6.27 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Safety evaluations in trials suggest Retatrutide is unsuitable for individuals with a family history of certain cancers
Visual and olfactory indicators help assess solution status
Hormonal Changes Hormonal fluctuations may contribute to melasma, a condition characterised by symmetrical brown or greyish patches, commonly affecting the cheeks, forehead, or upper lip
Retatrutide is a potent triple agonist peptide specifically designed to target the GLP-1, GIP, and glucagon (GCGR) receptors
Urgent medical attention required: Patients should seek immediate medical help (call 999 or attend A&E) if they experience actual loss of consciousness (syncope), chest pain, severe breathlessness, slurred speech, facial drooping, weakness on one side of the body, or severe headache
US$ 20.71
US$ 20.88
&srotate=0)
US$ 21.88
US$ 27.38
US$ 23.78
US$ 21.99
